Cargando…
The Promise of JAK Inhibitors for Treatment of Sarcoidosis and Other Inflammatory Disorders with Macrophage Activation: A Review of the Literature
Certain inflammatory disorders are characterized by macrophage activation and accumulation in tissue; sometimes leading to the formation of granulomas, as in sarcoidosis. These disorders are often difficult to treat and more effective, molecularly targeted therapies are needed. Recent work has shown...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087061/ https://www.ncbi.nlm.nih.gov/pubmed/32226347 |
_version_ | 1783509258080354304 |
---|---|
author | Wang, Alice Singh, Katelyn Ibrahim, Wael King, Brett Damsky, William |
author_facet | Wang, Alice Singh, Katelyn Ibrahim, Wael King, Brett Damsky, William |
author_sort | Wang, Alice |
collection | PubMed |
description | Certain inflammatory disorders are characterized by macrophage activation and accumulation in tissue; sometimes leading to the formation of granulomas, as in sarcoidosis. These disorders are often difficult to treat and more effective, molecularly targeted therapies are needed. Recent work has shown that overproduction of inflammatory cytokines, such as interferon gamma (IFN-γ) leading to constitutive activation of the JAK-STAT pathway may be a conserved feature of these disorders. Use of JAK inhibitors, which can block these signals, has resulted in dramatic improvement in several patients with sarcoidosis. JAK inhibitors also appear to have activity in other inflammatory disorders with macrophage activation including hemophagocytic lymphohistiocystosis, Crohn’s disease, granuloma annulare, and necrobiosis lipoidica. Here, we review the role of JAK dependent cytokines in macrophage activation and granuloma formation and the clinical evidence supporting the use of JAK inhibition in these disorders. Ongoing efforts to evaluate role of JAK inhibitors in these disorders is also discussed. |
format | Online Article Text |
id | pubmed-7087061 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | YJBM |
record_format | MEDLINE/PubMed |
spelling | pubmed-70870612020-03-27 The Promise of JAK Inhibitors for Treatment of Sarcoidosis and Other Inflammatory Disorders with Macrophage Activation: A Review of the Literature Wang, Alice Singh, Katelyn Ibrahim, Wael King, Brett Damsky, William Yale J Biol Med Mini-Review Certain inflammatory disorders are characterized by macrophage activation and accumulation in tissue; sometimes leading to the formation of granulomas, as in sarcoidosis. These disorders are often difficult to treat and more effective, molecularly targeted therapies are needed. Recent work has shown that overproduction of inflammatory cytokines, such as interferon gamma (IFN-γ) leading to constitutive activation of the JAK-STAT pathway may be a conserved feature of these disorders. Use of JAK inhibitors, which can block these signals, has resulted in dramatic improvement in several patients with sarcoidosis. JAK inhibitors also appear to have activity in other inflammatory disorders with macrophage activation including hemophagocytic lymphohistiocystosis, Crohn’s disease, granuloma annulare, and necrobiosis lipoidica. Here, we review the role of JAK dependent cytokines in macrophage activation and granuloma formation and the clinical evidence supporting the use of JAK inhibition in these disorders. Ongoing efforts to evaluate role of JAK inhibitors in these disorders is also discussed. YJBM 2020-03-27 /pmc/articles/PMC7087061/ /pubmed/32226347 Text en Copyright ©2020, Yale Journal of Biology and Medicine https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons CC BY-NC license, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use the material for commercial purposes. |
spellingShingle | Mini-Review Wang, Alice Singh, Katelyn Ibrahim, Wael King, Brett Damsky, William The Promise of JAK Inhibitors for Treatment of Sarcoidosis and Other Inflammatory Disorders with Macrophage Activation: A Review of the Literature |
title | The Promise of JAK Inhibitors for Treatment of Sarcoidosis and Other Inflammatory Disorders with Macrophage Activation: A Review of the Literature |
title_full | The Promise of JAK Inhibitors for Treatment of Sarcoidosis and Other Inflammatory Disorders with Macrophage Activation: A Review of the Literature |
title_fullStr | The Promise of JAK Inhibitors for Treatment of Sarcoidosis and Other Inflammatory Disorders with Macrophage Activation: A Review of the Literature |
title_full_unstemmed | The Promise of JAK Inhibitors for Treatment of Sarcoidosis and Other Inflammatory Disorders with Macrophage Activation: A Review of the Literature |
title_short | The Promise of JAK Inhibitors for Treatment of Sarcoidosis and Other Inflammatory Disorders with Macrophage Activation: A Review of the Literature |
title_sort | promise of jak inhibitors for treatment of sarcoidosis and other inflammatory disorders with macrophage activation: a review of the literature |
topic | Mini-Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087061/ https://www.ncbi.nlm.nih.gov/pubmed/32226347 |
work_keys_str_mv | AT wangalice thepromiseofjakinhibitorsfortreatmentofsarcoidosisandotherinflammatorydisorderswithmacrophageactivationareviewoftheliterature AT singhkatelyn thepromiseofjakinhibitorsfortreatmentofsarcoidosisandotherinflammatorydisorderswithmacrophageactivationareviewoftheliterature AT ibrahimwael thepromiseofjakinhibitorsfortreatmentofsarcoidosisandotherinflammatorydisorderswithmacrophageactivationareviewoftheliterature AT kingbrett thepromiseofjakinhibitorsfortreatmentofsarcoidosisandotherinflammatorydisorderswithmacrophageactivationareviewoftheliterature AT damskywilliam thepromiseofjakinhibitorsfortreatmentofsarcoidosisandotherinflammatorydisorderswithmacrophageactivationareviewoftheliterature AT wangalice promiseofjakinhibitorsfortreatmentofsarcoidosisandotherinflammatorydisorderswithmacrophageactivationareviewoftheliterature AT singhkatelyn promiseofjakinhibitorsfortreatmentofsarcoidosisandotherinflammatorydisorderswithmacrophageactivationareviewoftheliterature AT ibrahimwael promiseofjakinhibitorsfortreatmentofsarcoidosisandotherinflammatorydisorderswithmacrophageactivationareviewoftheliterature AT kingbrett promiseofjakinhibitorsfortreatmentofsarcoidosisandotherinflammatorydisorderswithmacrophageactivationareviewoftheliterature AT damskywilliam promiseofjakinhibitorsfortreatmentofsarcoidosisandotherinflammatorydisorderswithmacrophageactivationareviewoftheliterature |